Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Oxford Biodynamics stock

OBD.L
GB00BD5H8572
A2DH0R

Price

0.01
Today +/-
+0
Today %
+0 %

Oxford Biodynamics stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Oxford Biodynamics stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Oxford Biodynamics stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Oxford Biodynamics stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Oxford Biodynamics's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Oxford Biodynamics Stock Price History

DateOxford Biodynamics Price
12/23/20240.01 undefined
12/20/20240.01 undefined
12/19/20240.01 undefined
12/18/20240.01 undefined
12/17/20240.01 undefined
12/16/20240.01 undefined
12/13/20240.01 undefined
12/12/20240.01 undefined
12/11/20240.01 undefined
12/10/20240.01 undefined
12/9/20240.01 undefined
12/6/20240.01 undefined
12/5/20240.01 undefined
12/4/20240.02 undefined
12/3/20240.02 undefined
12/2/20240.01 undefined
11/29/20240.01 undefined
11/28/20240.01 undefined
11/27/20240.01 undefined
11/26/20240.01 undefined
11/25/20240.01 undefined

Oxford Biodynamics Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Oxford Biodynamics, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Oxford Biodynamics from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Oxford Biodynamics’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Oxford Biodynamics. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Oxford Biodynamics’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Oxford Biodynamics’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Oxford Biodynamics’s growth potential.

Oxford Biodynamics Revenue, EBIT and net profit per share

DateOxford Biodynamics RevenueOxford Biodynamics EBITOxford Biodynamics Net Income
2025e1.91 M undefined-12.4 M undefined-113,247.48 undefined
2024e648,900 undefined-13.17 M undefined-135,896.97 undefined
2023510,000 undefined-10.17 M undefined-10.83 M undefined
2022154,000 undefined-8.6 M undefined-6.71 M undefined
2021341,000 undefined-7.51 M undefined-6.68 M undefined
2020456,000 undefined-4.95 M undefined-4.35 M undefined
2019907,000 undefined-3.72 M undefined-2.8 M undefined
20181.19 M undefined-2.6 M undefined-1.95 M undefined
20171.18 M undefined-2.51 M undefined-3.8 M undefined
20161.09 M undefined-1.88 M undefined-1.73 M undefined
2015702,000 undefined-1.61 M undefined-1.01 M undefined
2014660,000 undefined-770,000 undefined-740,000 undefined
2013350,000 undefined-1.09 M undefined-1.06 M undefined

Oxford Biodynamics Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (k)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
201320142015201620172018201920202021202220232024e2025e
0001,0001,0001,0000000001,000
-------------
-------------
0000000000000
-10-1-1-3-1-2-4-6-6-1000
----200.00-66.67100.00100.0050.00-66.67--
86.186.186.181.685.2787.7392.5692.5692.5699.7147.4800
-------------
Details

Keystats

ⓘ

Revenue and Growth

The Oxford Biodynamics Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Oxford Biodynamics is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (k)OTHER REC. (M)INVENTORIES (k)OTHER CURRENT LIAB. (k)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (k)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (k)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (k)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (k)OTHER LIAB. (k)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
20132014201520162017201820192020202120222023
                     
3.025.58.447.2810.818.2815.511.514.3415.25
2302808034031235205323621243
0.210.270.560.510.710.810.720.81.351.071.01
0206010590146243323392337274
403090113287156258220240347591
3.56.19.238.3511.9119.6216.9212.886.682.777.17
0.10.090.510.670.750.970.891.187.556.987
0000004220000
000000001.351.070
00000.010.350.560.871.151.61.91
00000000000
000000000050
0.10.090.510.670.771.321.872.0510.059.658.96
3.66.199.749.0212.6820.9418.7914.9316.7312.4116.13
                     
0000.820.860.930.930.930.9312.02
8.2911.2115.7106.5316.716.7416.7416.7419.0232.14
-5.58-6.19-6.856.723.992.23-0.29-4.72-11.15-17.56-28.05
210200170190192177203193159119-63
00000000000
2.925.229.037.7211.5820.0317.5713.146.682.596.06
00.060.080.280.260.290.180.310.60.92.19
0.630.870.580.910.730.490.850.730.9911.12
0.030.030.040.050.050.050.080.120.080.281.58
00000000000
0000000130634736818
0.660.960.71.231.030.821.111.292.32.915.71
00000000.415.955.45.62
00000009302110
0004457709265408424440
0000.040.060.070.090.496.395.856.07
0.660.960.71.281.080.891.21.778.698.7611.78
3.586.189.73912.6620.9218.7714.9115.3611.3417.83
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Oxford Biodynamics provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Oxford Biodynamics's financial health and stability.

Assets

Oxford Biodynamics's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Oxford Biodynamics must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Oxford Biodynamics after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Oxford Biodynamics's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (k)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (k)NON-CASH ITEM (k)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20132014201520162017201820192020202120222023
-10-1-1-3-2-3-4-7-7-11
000000001,0001,0001,000
00000000000
0000000001,0000
00001,000000001,000
00000000000
00000000000
00-1-1-1-1-2-3-5-5-8
00000000-300
000000-114210
000000-105520
00000000000
00000000000
0240710000315
0240510000213
-----1.00------1.00
00000000000
022-137-130-3-14
0.08-0.46-1.75-1.56-1.95-2.72-2.9-3.86-9.01-6.08-9.01
00000000000

Oxford Biodynamics stock margins

The Oxford Biodynamics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Oxford Biodynamics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Oxford Biodynamics.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Oxford Biodynamics's sales revenue. A higher gross margin percentage indicates that the Oxford Biodynamics retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Oxford Biodynamics's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Oxford Biodynamics's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Oxford Biodynamics's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Oxford Biodynamics. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Oxford Biodynamics's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Oxford Biodynamics Margin History

Oxford Biodynamics Gross marginOxford Biodynamics Profit marginOxford Biodynamics EBIT marginOxford Biodynamics Profit margin
2025e52.16 %-649.44 %-5.93 %
2024e52.16 %-2,029.21 %-20.94 %
202352.16 %-1,993.73 %-2,122.75 %
202275.32 %-5,585.06 %-4,357.14 %
202152.16 %-2,202.93 %-1,959.53 %
202052.16 %-1,085.75 %-953.73 %
201952.16 %-410.47 %-308.71 %
201852.16 %-219.39 %-164.67 %
201752.16 %-212.43 %-321.56 %
201652.16 %-172.41 %-158.57 %
201552.16 %-229.06 %-143.16 %
201452.16 %-116.67 %-112.12 %
201352.16 %-311.43 %-302.86 %

Oxford Biodynamics Stock Sales Revenue, EBIT, Earnings per Share

The Oxford Biodynamics earnings per share therefore indicates how much revenue Oxford Biodynamics has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Oxford Biodynamics earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Oxford Biodynamics's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Oxford Biodynamics’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Oxford Biodynamics's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Oxford Biodynamics Revenue, EBIT and net profit per share

DateOxford Biodynamics Sales per ShareOxford Biodynamics EBIT per shareOxford Biodynamics Earnings per Share
2025e0.01 undefined0 undefined-0 undefined
2024e0 undefined0 undefined-0 undefined
20230 undefined-0.07 undefined-0.07 undefined
20220 undefined-0.09 undefined-0.07 undefined
20210 undefined-0.08 undefined-0.07 undefined
20200 undefined-0.05 undefined-0.05 undefined
20190.01 undefined-0.04 undefined-0.03 undefined
20180.01 undefined-0.03 undefined-0.02 undefined
20170.01 undefined-0.03 undefined-0.04 undefined
20160.01 undefined-0.02 undefined-0.02 undefined
20150.01 undefined-0.02 undefined-0.01 undefined
20140.01 undefined-0.01 undefined-0.01 undefined
20130 undefined-0.01 undefined-0.01 undefined

Oxford Biodynamics business model

Oxford Biodynamics PLC is a company specialized in the development and application of epigenetic technologies. It was founded in 2007 in Oxford, United Kingdom and has since then had an impressive track record in researching and developing new methods for the detection and treatment of diseases. The business model of Oxford Biodynamics is to utilize its proprietary technology platform, EpiSwitch®, to offer validation and screening services to customers in the pharmaceutical and biotech industries. Oxford Biodynamics' technology platform utilizes epigenetic information to diagnose and predict diseases. The company also uses its technology to identify biomarkers that provide unique insights into the biological processes associated with specific diseases. Oxford Biodynamics operates in three main areas: diagnostics, research and development, and nanoparticle technology. In the diagnostics field, the company offers blood tests for early detection of breast cancer and other types of cancer. The tests utilize a combination of epigenetic signatures and artificial intelligence to deliver results. Oxford Biodynamics is also developing a test to aid in the diagnosis of neurodegenerative diseases such as Parkinson's and Alzheimer's. In the research and development field, Oxford Biodynamics collaborates closely with pharmaceutical and biotech companies to identify epigenetic signatures specific to certain diseases. The company has already worked with major pharmaceutical companies to test the effectiveness of drugs in treating lung cancer and breast cancer. Oxford Biodynamics has also started a collaboration with the John Radcliffe Hospital in Oxford to develop new epigenetics-based methods for predicting premature births. In the nanoparticle technology field, the company utilizes its expertise in epigenetics to develop new technologies that enhance drug delivery and increase the therapeutic effects of medications. The company is currently developing a new type of nanoparticles specifically designed to target cancer cells. These nanoparticles are able to selectively concentrate on cancer cells and directly enter the targeted tissue, minimizing unwanted side effects and maximizing effectiveness. Overall, Oxford Biodynamics is a leading company in epigenetics research and technology development. The company has already made significant advancements in developing new diagnostic and therapeutic methods for various diseases and is constantly working to improve its technologies and expand its product range. The future of the company looks very promising as epigenetics becomes increasingly important in medical research and diagnostics, and Oxford Biodynamics is one of the leading companies in this field. Oxford Biodynamics is one of the most popular companies on Eulerpool.com.

Oxford Biodynamics SWOT Analysis

Strengths

Oxford Biodynamics PLC possesses several strengths that contribute to its competitive advantage in the market:

  • Advanced Technology: The company utilizes cutting-edge technologies in the field of biomarkers and epigenetics, allowing for accurate and reliable data analysis.
  • Strong Intellectual Property: Oxford Biodynamics PLC holds a robust portfolio of patents and intellectual property rights, providing protection for its innovative solutions.
  • Expertise and Knowledge: The company has a highly skilled team of scientists and researchers who are experts in their respective fields, enabling them to develop and enhance their technological capabilities.
  • Strategic Partnerships: Oxford Biodynamics PLC has established strategic collaborations with renowned research institutions and industry leaders, facilitating knowledge sharing and expanding market reach.

Weaknesses

Despite its strengths, Oxford Biodynamics PLC also faces certain weaknesses that may hinder its growth and performance:

  • Reliance on Research Funding: The company heavily depends on research grants and funding, which may be subject to fluctuations and restrictions, impacting its financial stability and growth potential.
  • Market Dependency: Oxford Biodynamics PLC's products and services are highly specialized, making its success susceptible to changes in the demand and adoption of its offerings within the market.
  • High Research and Development Costs: The development and refinement of advanced technologies involve significant financial investments, putting pressure on the company's financial resources and profitability.

Opportunities

Oxford Biodynamics PLC can leverage various opportunities to further enhance its position and drive growth:

  • Expanding Applications: The company can explore new applications and markets for its technology, such as personalized medicine, drug development, and diagnostics, opening avenues for revenue diversification.
  • Global Market Expansion: With its strong intellectual property and technological expertise, Oxford Biodynamics PLC can expand its operations internationally, tapping into new geographical markets and customer segments.
  • Industry Collaborations: Forming strategic alliances with pharmaceutical companies and clinical research organizations can accelerate the adoption of the company's solutions and increase market penetration.

Threats

Oxford Biodynamics PLC faces certain threats that could impact its growth and profitability:

  • Regulatory Challenges: Evolving regulations in the healthcare industry may require compliance measures that increase costs or delay product approvals, affecting the company's time-to-market and competitiveness.
  • Competition: The market for biomarkers and epigenetics is highly competitive, with the presence of established players and emerging startups. Oxford Biodynamics PLC must differentiate its offerings and continually innovate to maintain its market position.
  • Economic Conditions: Economic downturns and financial instability can lead to reduced research funding and discretionary spending, potentially impacting the demand for the company's solutions.
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Oxford Biodynamics Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Oxford Biodynamics historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Oxford Biodynamics shares outstanding

The number of shares was Oxford Biodynamics in 2023 — This indicates how many shares 147.482 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Oxford Biodynamics earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Oxford Biodynamics's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Oxford Biodynamics’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Oxford Biodynamics's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Oxford Biodynamics.

Oxford Biodynamics shareholders

%
Name
Stocks
Change
Date
9.43973 % Vulpes Investment Management Private Limited29,653,9782,222,2224/8/2024
8.00010 % Unicorn Asset Management Ltd.25,131,5268,313,3454/8/2024
5.87707 % Arbuthnot Latham & Co. Limited18,462,23501/15/2024
4.95601 % Lombard Odier Asset Management (Europe) Ltd15,568,816-181,18410/14/2024
3.36716 % Ahiska (Yavuz)10,577,60010,577,60010/2/2024
3.17655 % Seneca Partners Limited9,978,82201/15/2024
2.55377 % Cantor Fitzgerald Europe8,022,4178,022,4174/5/2024
2.33013 % Investec Wealth & Investment Limited7,319,88601/15/2024
2.20806 % Akoulitchev (Alexandre)6,936,415333,3334/8/2024
1.94535 % Crux Asset Management Limited6,111,11107/31/2024
1
2
3
4
5
...
10

Oxford Biodynamics Executives and Management Board

Dr. Jon Anthony Joseph Burrows

(60)
Oxford Biodynamics Chief Executive Officer, Executive Director (since 2020)
Compensation 506,000

Dr. Alexandre Akoulitchev

(58)
Oxford Biodynamics Chief Scientific Officer, Executive Director (since 2007)
Compensation 215,000

Mr. Paul Stockdale

Oxford Biodynamics Chief Financial Officer, Executive Director (since 2017)
Compensation 193,000

Mr. Matthew Wakefield

(63)
Oxford Biodynamics Non-Executive Independent Chairman of the Board
Compensation 78,000

Dr. David Holbrook

(60)
Oxford Biodynamics Non-Executive Independent Director
Compensation 42,000
1
2

Most common questions regarding Oxford Biodynamics

What values and corporate philosophy does Oxford Biodynamics represent?

Oxford Biodynamics PLC represents a commitment to revolutionizing personalized medicine through the application of biomarkers and genomic profiling. The company's core values prioritize scientific excellence, innovation, and collaboration to drive advancements in healthcare. Oxford Biodynamics PLC is dedicated to delivering accurate and reliable diagnostic solutions that enable early detection and monitoring of diseases, ultimately improving patient care and treatment outcomes. By leveraging its proprietary EpiSwitch™ technology, the company aims to transform the field of precision medicine, providing meaningful insights for drug discovery and development. Oxford Biodynamics PLC is driven by a strong corporate philosophy focused on scientific rigor, integrity, and a patient-centric approach.

In which countries and regions is Oxford Biodynamics primarily present?

Oxford Biodynamics PLC primarily operates and is present in various countries and regions around the world. The company has a global presence, with activities and partnerships in North America, Europe, and Asia. It collaborates with leading academic institutions, pharmaceutical companies, and research organizations in these regions. Oxford Biodynamics PLC's commitment to expanding its reach and establishing a strong international presence allows it to tap into a diverse range of markets and opportunities, strengthening its position in the global biotechnology industry.

What significant milestones has the company Oxford Biodynamics achieved?

Since its establishment, Oxford Biodynamics PLC has achieved several significant milestones that have propelled its growth and success. The company has made remarkable advancements in its proprietary EpiSwitch technology, which enables the detection and monitoring of diseases at an early stage. Oxford Biodynamics PLC has successfully developed collaborations with renowned institutions and organizations, paving the way for groundbreaking research and clinical applications. With its cutting-edge technology and strong scientific expertise, the company continues to make strides in the field of predictive biomarkers and personalized medicine. Oxford Biodynamics PLC's notable achievements further solidify its position as a leader in the healthcare industry.

What is the history and background of the company Oxford Biodynamics?

Oxford Biodynamics PLC is a UK-based biotechnology company specializing in biomarker discovery and diagnostics. The company was founded in 2007 by University of Oxford professors, Sir Shankar Balasubramanian and Sir Edwin Southern. Oxford Biodynamics utilizes its proprietary EpiSwitch™ technology to analyze the epigenome and identify biomarkers that can be used for personalized medicine and drug development. The company's innovative approach has gained recognition within the industry, leading to numerous collaborations with pharmaceutical companies and academic institutions. With a strong focus on research and development, Oxford Biodynamics continues to make strides in the field of epigenetics and is poised to contribute significantly to advancements in healthcare.

Who are the main competitors of Oxford Biodynamics in the market?

Some of the main competitors of Oxford Biodynamics PLC in the market include companies like Illumina Inc., QIAGEN N.V., Bio-Rad Laboratories Inc., and Veracyte Inc. These companies also operate in the field of molecular biology and diagnostic testing, providing similar products and services. However, Oxford Biodynamics PLC distinguishes itself through its proprietary EpiSwitch™ technology, which enables highly accurate and non-invasive diagnostics with potential applications in various areas such as oncology and personalized medicine.

In which industries is Oxford Biodynamics primarily active?

Oxford Biodynamics PLC is primarily active in the biotechnology industry.

What is the business model of Oxford Biodynamics?

Oxford Biodynamics PLC's business model is focused on the development and commercialization of biomarker discovery and diagnostic products. The company utilizes its proprietary technology platform, EpiSwitch™, to identify and analyze changes in the epigenetic signature of cells. By studying these epigenetic changes, Oxford Biodynamics can identify biomarkers that are linked to various diseases and conditions. These biomarkers can then be used for diagnostic purposes, drug development, and personalized healthcare. With a strong emphasis on epigenetics, Oxford Biodynamics aims to provide innovative solutions for improving patient outcomes and advancing precision medicine.

What is the P/E ratio of Oxford Biodynamics 2024?

The Oxford Biodynamics P/E ratio is -12.72.

What is the P/S ratio of Oxford Biodynamics 2024?

The Oxford Biodynamics P/S ratio is 2.66.

What is the Quality Investing of Oxford Biodynamics?

The Quality Investing for Oxford Biodynamics is 5/10.

What is the revenue of Oxford Biodynamics 2024?

The expected Oxford Biodynamics revenue is 648,900 GBP.

How high is the profit of Oxford Biodynamics 2024?

The expected Oxford Biodynamics profit is -135,896.97 GBP.

What is the business model of Oxford Biodynamics

Oxford Biodynamics PLC (OBD) is a UK-based biotechnology company focused on the development of non-invasive diagnostic and prognostic tools based on epigenetics. The company utilizes the latest technologies and methods to gain a comprehensive understanding of epigenetic processes and convert them into medically actionable data. OBD has two main business segments: diagnostics and pharma. In the diagnostics field, the company focuses on developing biomarkers based on epigenetic changes associated with specific diseases. These biomarkers serve as non-invasive prognostic and diagnostic tools, enabling physicians and researchers to detect and treat diseases early. Diseases for which OBD offers diagnostic solutions include cancer, Alzheimer's, and Parkinson's. In the pharma sector, OBD collaborates with pharmaceutical companies to develop epigenetic therapies that have the potential to cure diseases or alleviate their symptoms. These therapies are based on understanding how epigenetic processes influence gene expression and how they can be manipulated to address specific disease causes. Diseases for which OBD offers pharma solutions include cancer, Alzheimer's, inflammation, and autoimmune diseases. One of the technologies OBD uses to develop its products and services is EpiSwitch, a proprietary platform that allows monitoring changes in the epigenetic signature of cells. By analyzing epigenetics, OBD can create a comprehensive profile of an individual's DNA, gaining a better understanding of the underlying epigenetic processes associated with disease onset and progression. OBD also offers customized services and solutions to meet the needs of its clients. These services include epigenetic profiling, diagnostic and prognostic tools, and consulting services. With these services, OBD can develop customized solutions that meet the needs of pharmaceutical companies, research institutions, and government agencies. Overall, OBD's business model is based on leveraging the latest technologies and methods to gain a better understanding of epigenetic processes associated with diseases. By developing non-invasive diagnostic and prognostic tools, as well as epigenetic therapies, OBD offers solutions that have the potential to save and improve many lives.

What is the Oxford Biodynamics dividend?

Oxford Biodynamics pays a dividend of 0 GBP distributed over payouts per year.

How often does Oxford Biodynamics pay dividends?

The dividend cannot currently be calculated for Oxford Biodynamics or the company does not pay out a dividend.

What is the Oxford Biodynamics ISIN?

The ISIN of Oxford Biodynamics is GB00BD5H8572.

What is the Oxford Biodynamics WKN?

The WKN of Oxford Biodynamics is A2DH0R.

What is the Oxford Biodynamics ticker?

The ticker of Oxford Biodynamics is OBD.L.

How much dividend does Oxford Biodynamics pay?

Over the past 12 months, Oxford Biodynamics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Oxford Biodynamics is expected to pay a dividend of 0 GBP.

What is the dividend yield of Oxford Biodynamics?

The current dividend yield of Oxford Biodynamics is .

When does Oxford Biodynamics pay dividends?

Oxford Biodynamics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Oxford Biodynamics?

Oxford Biodynamics paid dividends every year for the past 0 years.

What is the dividend of Oxford Biodynamics?

For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.

In which sector is Oxford Biodynamics located?

Oxford Biodynamics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Oxford Biodynamics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Oxford Biodynamics from 12/24/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 12/24/2024.

When did Oxford Biodynamics pay the last dividend?

The last dividend was paid out on 12/24/2024.

What was the dividend of Oxford Biodynamics in the year 2023?

In the year 2023, Oxford Biodynamics distributed 0 GBP as dividends.

In which currency does Oxford Biodynamics pay out the dividend?

The dividends of Oxford Biodynamics are distributed in GBP.

All fundamentals about Oxford Biodynamics

Our stock analysis for Oxford Biodynamics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Oxford Biodynamics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.